跳至主要内容
临床试验/CTRI/2023/05/053112
CTRI/2023/05/053112尚未招募2 期

A Clinical Study to Evaluate the Efficacy of Pippalyadigutika Anjana and Lohadi Guggulu in the Management of Shukla Arma (Non-Progressive Pterygium)

Dr Lakhwinder Singh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. The person with age of >20 years and <70years.
  • 2. Patients with sign and symptoms of Shukla Arma (Non-progressive
  • pterygium) will be selected irrespective of Sex, Religion and
  • Profession.
  • 3. Clinical Features like White Fleshy Growth in Suklamandalam white
  • portion of eyes), foreign body sensation, and watering of eyes.
  • 4. Patients those are fit for Anjana Karma according to Ayurveda text.
  • Patient willing to register for trial.

排除标准

  • 01. Age : < 20 years and >70 years
  • 02. Anjana Ayogya
  • 03. Progressive pterygium
  • 04. The patients in which Pterygium covers the pupillary margin.
  • 05. Prastari Arma, Lohita Arma, Adhimamsa Arma, Snayu Arma
  • 06. Arma (fleshy mass on the white portion of eyes) with any other
  • ocular pathologies like Abhisyanda, Adhimantha, etc.
  • 07. Pseudopterygium
  • 08. Chemical injury: e.g., Lime burn or any other
  • 09. Chronic viral infections:
  • e.g., Hepatitis C, HIV etc.
  • 10. Neurological conditions:
  • e.g., Parkinson disease, Bellâ??s palsy, Trigeminal neuralgia
  • 11. Immunological diseases â?? Autoimmune disease, collagen vascular
  • and immunodeficiency.
  • 12. Pregnancy
  • 13. Diabetes mellitus
  • 14. Hyperlipidaemia
  • 15. Hypertension
  • 16. Patients not willing to be registered for trial.

研究者

发起方
Dr Lakhwinder Singh

相似试验